Macrocyclic renin inhibitors: Synthesis of a subnanomolar, orally active cysteine derived inhibitor
- 29 October 1993
- journal article
- Published by Elsevier in Tetrahedron Letters
- Vol. 34 (44) , 7035-7038
- https://doi.org/10.1016/s0040-4039(00)61590-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Highly potent, orally active diester macrocyclic human renin inhibitorsJournal of Medicinal Chemistry, 1992
- The synthesis of potent marcocyclic renin inhibitorsTetrahedron Letters, 1992
- The design and synthesis of cyclic renin inhibitorsTetrahedron Letters, 1991
- The synthesis of novel macrocyclic inhibitors of human reninTetrahedron Letters, 1991
- Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitorsJournal of Medicinal Chemistry, 1991
- Conformationally constrained renin inhibitory peptides: cyclic (3-1)-1-(carboxymethyl)-L-prolyl-L-phenylalanyl-L-histidinamide as a conformational restriction at the P2-P4 tripeptide portion of the angiotensinogen templateJournal of Medicinal Chemistry, 1991
- Renin inhibitorsMedicinal Research Reviews, 1990
- Potent human renin inhibitors containing novel small cyclic peptides and stable to chymotrypsin degradationJournal of the Chemical Society, Chemical Communications, 1990
- Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogs of angiotensinogenJournal of Medicinal Chemistry, 1988
- Recent developments in the design of angiotensin‐converting enzyme inhibitorsMedicinal Research Reviews, 1985